Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Antonuzzo

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Cancers|June 28, 2023
Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma: Current Evidence and Future DirectionsEnrico Sammarco, Fiorella Manfredi, Amedeo Nuzzo, et al.
Biomedical Reports|March 20, 2020
Clinical and economic effect of administration of red blood product transfusions in an outpatient supportive care cancer serviceAndrea Sbrana, Federico Paolieri, Francesco Bloise, et al.
Endocrine|February 9, 2018
Practical issues for the management of hyponatremia in oncologyRossana Berardi, Andrea Antonuzzo, Livio Blasi, et al.
Journal of Geriatric Oncology|November 2, 2019
Effectiveness of Multi-Prognostic Index in older patients with advanced malignancies treated with immunotherapyAndrea Sbrana, Rachele Antognoli, Giuseppe Pasqualetti, et al.
Expert Opinion on Drug Safety|February 2, 2020
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approachesPaolo Bossi, Mario Airoldi, Maria Antonietta Aloe Spiriti, et al.
Future Oncology (London, England)|June 27, 2019
Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapyPaolo Bossi, Laura Botta, Paolo Bironzo, et al.
Tumori|July 23, 2021
Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinibElena Bolzacchini, Monica Giordano, Lorenza Bertù, et al.
JCO Oncology Practice|April 27, 2026
Attitudes, Practices, and Barriers to Spiritual Care for Patients With Cancer: An International SurveyCarla Ida Ripamonti, Junita Henry, Christina M Puchalski, et al.
Cancer|August 12, 2014
Docetaxel plus oral metronomic cyclophosphamide: a phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patientsLisa Derosa, Luca Galli, Paola Orlandi, et al.
ESMO Open|April 10, 2019
Interprofessional spiritual care in oncology: a literature reviewChristina M Puchalski, Andrea Sbrana, Betty Ferrell, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cancers|June 28, 2023
Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma: Current Evidence and Future DirectionsEnrico Sammarco, Fiorella Manfredi, Amedeo Nuzzo, et al.
Biomedical Reports|March 20, 2020
Clinical and economic effect of administration of red blood product transfusions in an outpatient supportive care cancer serviceAndrea Sbrana, Federico Paolieri, Francesco Bloise, et al.
Endocrine|February 9, 2018
Practical issues for the management of hyponatremia in oncologyRossana Berardi, Andrea Antonuzzo, Livio Blasi, et al.
Journal of Geriatric Oncology|November 2, 2019
Effectiveness of Multi-Prognostic Index in older patients with advanced malignancies treated with immunotherapyAndrea Sbrana, Rachele Antognoli, Giuseppe Pasqualetti, et al.
Expert Opinion on Drug Safety|February 2, 2020
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approachesPaolo Bossi, Mario Airoldi, Maria Antonietta Aloe Spiriti, et al.
Future Oncology (London, England)|June 27, 2019
Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapyPaolo Bossi, Laura Botta, Paolo Bironzo, et al.
Tumori|July 23, 2021
Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinibElena Bolzacchini, Monica Giordano, Lorenza Bertù, et al.
JCO Oncology Practice|April 27, 2026
Attitudes, Practices, and Barriers to Spiritual Care for Patients With Cancer: An International SurveyCarla Ida Ripamonti, Junita Henry, Christina M Puchalski, et al.
Cancer|August 12, 2014
Docetaxel plus oral metronomic cyclophosphamide: a phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patientsLisa Derosa, Luca Galli, Paola Orlandi, et al.
ESMO Open|April 10, 2019
Interprofessional spiritual care in oncology: a literature reviewChristina M Puchalski, Andrea Sbrana, Betty Ferrell, et al.
Pageof 6